ArticleJournal of medicinal chemistry2026
Benchmarking Large Language Models for Drug Combination Alerts: Achieving Expert-Level Reliability via Knowledge Grounding and Contextual Reasoning.
Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Large Language Models in Adverse Drug Reaction Detection and Pharmacovigilance: A Systematic Review of Current Applications, Challenges, and Future Directions.Diagnostics (Basel, Switzerland) · 2026Review
- scPD: a Python package for inferring continuous population dynamics from single-cell snapshot data.Bioinformatics advances · 2026Article
- A comparative study of the performance of different large language models in the Chinese National Pharmacist Licensing Examination.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large language models (LLMs) have emerged as promising tools in the healthcare sector. However, their reliability in the critical task of identifying risky drug combinations remains unvalidated. Here, we systematically evaluated the potential of LLMs for drug combination alerting under the guidance of the CoMed framework through four aspects: (1) the baseline performance of native LLMs, (2) the contribution of external knowledge grounding via Retrieval-Augmented Generation (RAG), (3) the impact of expert-guided reasoning using context engineering, and (4) the utility of a multiagent architecture for comprehensive and interpretable risk analysis. Notably, by integrating RAG and the context engineering strategy, Qwen2.5-Max-CoT achieved outstanding performance (F1 = 0.971, AUC = 0.982), demonstrating expert-level balance between precision and recall. Furthermore, a case study on aspirin-warfarin validated CoMed's ability to generate accurate assessments in a structured and traceable HTML report. This study demonstrates that enhanced LLMs can reliably and transparently support drug combination risk alerting and clinical decision.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.